US Patent Issued to Zetagen Therapeutics on Sept. 2 for "Cancer treatments using modified fatty acids and the carriers to administer them" (New York, Texas Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,118, issued on Sept. 2, was assigned to Zetagen Therapeutics Inc. (Syracuse, N.Y.).

"Cancer treatments using modified fatty acids and the carriers to administer them" was invented by Bryan S. Margulies (Liverpool, N.Y.) and Joe C. Loy (Weatherford, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compositions comprising a lanthanide (III) modified fatty acid and methods of treating cancer with the composition. In particular, the application includes a lanthanide (III) modified fatty acid is a 9-R', 10-R" tri octadecanoate compound. This lanthanide (III) modified fatty acid can be combined with additional therapeutic agents, ...